Anne Carol Goldberg, MD, FACP, FAHA, FNLA is an endocrinologist and lipid specialist. Dr. Goldberg received her undergraduate degree from Radcliffe College/Harvard University in Boston, Massachusetts, and her medical degree from the University of Maryland. She completed internal medicine residency at Michael Reese Hospital in Chicago, Illinois, and fellowship training in Endocrinology at Washington University School of Medicine in St. Louis, Missouri. She then joined the faculty of Washington University School of Medicine, where she is a Professor of Medicine. Dr. Goldberg’s research and clinical interests include dietary modifications and drug therapies for hyperlipidemia and the treatment of familial hypercholesterolemia. She has conducted numerous clinical trials of lipid-modifying drugs and cardiovascular outcomes trials. In her practice, she treats adults and children with dyslipidemia with a particular interest in familial hypercholesterolemia and also has a lipoprotein apheresis program. Dr. Goldberg is a Fellow of the American College of Physicians, the American Heart Association, and the National Lipid Association. Awards include the National Forum Public Policy Award, National Forum for Heart Disease and Stroke Prevention, the President’s Service Award of the National Lipid Association, the Foundation of the National Lipid Association Clinician/Educator Award, and Washington University School of Medicine Distinguished Clinician Award.
She is a past President of the National Lipid Association and the immediate past president of the Foundation of the National Lipid Association. She chaired the National Lipid Association Expert Panel on Familial Hypercholesterolemia and was a member of the American College of Cardiology/American Heart Association Blood Cholesterol Expert Panel for the 2013 ACC/AHA Cholesterol Guidelines. She was a member of the task force for the development of the Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Hypertriglyceridemia. She is currently the Chief Science Officer of the National Lipid Association.